FI953360A - Substituoituja 1-(7-kloorikinol-4-yyli)pyratsoli-3-karboksiamidi-H-oksidijohdannaisia, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset - Google Patents
Substituoituja 1-(7-kloorikinol-4-yyli)pyratsoli-3-karboksiamidi-H-oksidijohdannaisia, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset Download PDFInfo
- Publication number
- FI953360A FI953360A FI953360A FI953360A FI953360A FI 953360 A FI953360 A FI 953360A FI 953360 A FI953360 A FI 953360A FI 953360 A FI953360 A FI 953360A FI 953360 A FI953360 A FI 953360A
- Authority
- FI
- Finland
- Prior art keywords
- chloroquinol
- carboxamide
- pyrazole
- substituted
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9408459A FR2722193B1 (fr) | 1994-07-08 | 1994-07-08 | Derives n-oxydes de 1-(7-chloro-4-quinoleinyl)pyrazole-3-carboxamides substitues, procede pour leur preparation et les compositions pharmaceitiques les contenant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI953360A0 FI953360A0 (fi) | 1995-07-07 |
| FI953360A true FI953360A (fi) | 1996-01-09 |
Family
ID=9465167
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI953360A FI953360A (fi) | 1994-07-08 | 1995-07-07 | Substituoituja 1-(7-kloorikinol-4-yyli)pyratsoli-3-karboksiamidi-H-oksidijohdannaisia, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5561234A (fi) |
| EP (1) | EP0695747A1 (fi) |
| JP (1) | JPH0841051A (fi) |
| KR (1) | KR960004341A (fi) |
| CN (1) | CN1042533C (fi) |
| AU (1) | AU695588B2 (fi) |
| CA (1) | CA2153432A1 (fi) |
| FI (1) | FI953360A (fi) |
| FR (1) | FR2722193B1 (fi) |
| HU (1) | HUT73175A (fi) |
| IL (1) | IL114500A (fi) |
| NO (1) | NO952715L (fi) |
| NZ (1) | NZ272525A (fi) |
| PL (1) | PL309546A1 (fi) |
| RU (1) | RU2145323C1 (fi) |
| TW (1) | TW318847B (fi) |
| ZA (1) | ZA955673B (fi) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0001316A3 (en) * | 1997-02-03 | 2001-10-29 | Mallinckrodt Inc | Method for the detection and localization of malignant human tumours |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5283852A (en) * | 1976-01-01 | 1977-07-13 | Christiaens Sa A | Pyridine derivatives |
| US4746671A (en) * | 1985-11-04 | 1988-05-24 | Janssen Pharmaceutica N.V. | Pharmaceutical use of [[[(3-pyridinyl)methylen]amino]oxy]alkanoic acids and esters |
| JPH02268162A (ja) * | 1989-04-10 | 1990-11-01 | Fujisawa Pharmaceut Co Ltd | ジフェニルピリジン誘導体 |
| FR2665898B1 (fr) * | 1990-08-20 | 1994-03-11 | Sanofi | Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
-
1994
- 1994-07-08 FR FR9408459A patent/FR2722193B1/fr not_active Expired - Fee Related
-
1995
- 1995-07-06 JP JP7170712A patent/JPH0841051A/ja active Pending
- 1995-07-06 EP EP95401626A patent/EP0695747A1/fr not_active Withdrawn
- 1995-07-06 TW TW084106976A patent/TW318847B/zh active
- 1995-07-07 AU AU24867/95A patent/AU695588B2/en not_active Ceased
- 1995-07-07 ZA ZA955673A patent/ZA955673B/xx unknown
- 1995-07-07 CA CA002153432A patent/CA2153432A1/en not_active Abandoned
- 1995-07-07 CN CN95109950A patent/CN1042533C/zh not_active Expired - Fee Related
- 1995-07-07 IL IL11450095A patent/IL114500A/xx active IP Right Grant
- 1995-07-07 FI FI953360A patent/FI953360A/fi unknown
- 1995-07-07 NZ NZ272525A patent/NZ272525A/en unknown
- 1995-07-07 RU RU95113184A patent/RU2145323C1/ru active
- 1995-07-07 US US08/499,726 patent/US5561234A/en not_active Expired - Fee Related
- 1995-07-07 NO NO952715A patent/NO952715L/no unknown
- 1995-07-07 HU HU9502081A patent/HUT73175A/hu unknown
- 1995-07-07 PL PL95309546A patent/PL309546A1/xx unknown
- 1995-07-08 KR KR1019950020074A patent/KR960004341A/ko active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| FI953360A0 (fi) | 1995-07-07 |
| NZ272525A (en) | 1997-02-24 |
| FR2722193A1 (fr) | 1996-01-12 |
| CA2153432A1 (en) | 1996-01-09 |
| ZA955673B (en) | 1996-02-20 |
| IL114500A0 (en) | 1995-11-27 |
| TW318847B (fi) | 1997-11-01 |
| IL114500A (en) | 1999-11-30 |
| CN1120042A (zh) | 1996-04-10 |
| FR2722193B1 (fr) | 1996-10-04 |
| PL309546A1 (en) | 1996-01-22 |
| NO952715L (no) | 1996-01-09 |
| JPH0841051A (ja) | 1996-02-13 |
| AU695588B2 (en) | 1998-08-20 |
| EP0695747A1 (fr) | 1996-02-07 |
| KR960004341A (ko) | 1996-02-23 |
| HUT73175A (en) | 1996-06-28 |
| RU2145323C1 (ru) | 2000-02-10 |
| AU2486795A (en) | 1996-01-18 |
| HU9502081D0 (en) | 1995-09-28 |
| NO952715D0 (no) | 1995-07-07 |
| CN1042533C (zh) | 1999-03-17 |
| US5561234A (en) | 1996-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI963566A0 (fi) | Uusia piperatsiinijohdoksia, menetelmiä niiden valmistamiseksi ja niitä sisältäviä koostumuksia | |
| FI964473A (fi) | Uudet aminohappojohdannaiset, menetelmä niiden valmistamiseksi ja näitä yhdisteitä sisältävät farmaseuttiset koostumukset (II) | |
| NO973479L (no) | Substituerte heterosykliske forbindelser, fremgangsmåte for fremstilling og farmasöytiske blandinger inneholdende samme | |
| EE04498B1 (et) | Erütromütsiini derivaadid, nende valmistamismeetod ja neid sisaldav farmatseutiline kompositsioon | |
| FI942913A0 (fi) | Isatiinijohdannaiset, menetelmät niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset | |
| EE03177B1 (et) | Heterobitsüklilised ühendid, nende saamismeetod ja nimetatud ühendeid sisaldavad farmatseutilised kompositsioonid | |
| EE200000707A (et) | Oksasolidinooni derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid | |
| EE03263B1 (et) | Erütromütsiini derivaadid, nende valmistamismeetod, farmatseutiline kompositsioon ja vaheühendid | |
| EE9700333A (et) | Substitueeritud 4-fenüülaminotiasoolid, nende valmistamise meetod ja neid sisaldavad farmakoloogilised kompositsioonid | |
| FI973279A (fi) | Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset | |
| EE04399B1 (et) | Spiroasabitsüklilised heterotsüklilised ühendid, nende valmistamise protsess, neid sisaldavad ravimkoostised ja nende kasutamine ravis | |
| FI943571A (fi) | 1-bentseenisulfonyyli-1,3-dihydro-2H-bentsimidatsol-2-onijohdannaisia, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset | |
| EE04489B1 (et) | Atsüülpseudodipeptiidid, nende valmistamise meetod ja neid sisaldavad farmatseutilised kompositsioonid | |
| EE9800426A (et) | Asendatud 2,4-tiasolidiindiooni derivaadid, nende valmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid | |
| EE03929B1 (et) | Sünteetilised polüsahhariidid, nende valmistamisemeetod ja neid sisaldavad farmatseutilised kompositsioonid | |
| EE03825B1 (et) | 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid | |
| FI950625A (fi) | Polysubstituoituja 3-asyyliamino-5-fenyyli-1,4-bentsodiatsepiini-2-onijohdannaisia, menetelmä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia | |
| KR950700310A (ko) | 헤테로트리사이클릭 유도체, 그의 제조방법 및 그를 함유하는 약제학적 조성물(heterotricyclic derivatives, process for their preparation and pharmaceutical compositions containing them) | |
| EE04346B1 (et) | Asoolid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon | |
| FI960316A (fi) | Oksatiolaanit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset | |
| FI956278A0 (fi) | Substituoituja 4-fenyylitiatsolijohdannaisia, menetelmä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia | |
| IT1205665B (it) | Derivati 1-(idrossistiril)-5h2,3-benzodiazepinici,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono | |
| EE9800264A (et) | Taksoidid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid | |
| EE03996B1 (et) | Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine | |
| FI951561A0 (fi) | Uudet 17 -substituoidut 4-androstaanijohdannaiset, niitä sisältävät farmaseuttiset koostumukset ja menetelmä niiden valmistamiseksi |